CECOG Immuno-Oncology Symposium
CECOG Academy
Combining Immune Checkpoint Inhibitors With Tyrosine Kinase Inhibitors in Solid Tumors
FEATURING
Thorsten Füreder
- 185 views
- December 13, 2021
- 1
CECOG Academy
Updates on Cabozantinib in RCC, HCC, and Thyroid Cancers
FEATURING
Bela Mrinakova
- 149 views
- December 10, 2021
- 1
CECOG Academy
Efficacy of FDA-Approved Lenvatinib in Solid Cancers
FEATURING
Adrian Perdyan
- 36 views
- December 10, 2021
CECOG Academy
From Bench to Bedside - CLL: Steps to Chemo-Free Therapy
FEATURING
Ulrich Jaeger
- 143 views
- December 10, 2021
- 1
CECOG Academy
SARS-CoV-2 Pandemic: Vaccination Against Coronavirus in Patients with Cancer
FEATURING
Ursula Wiedermann-Schmidt
- 33 views
- December 7, 2021
CECOG Academy
Advances in IO Maintenance Treatment of Ovarian Cancer
FEATURING
Christoph Grimm
- 372 views
- December 7, 2021
- 3
CECOG Academy
Adjuvant Treatment of Colon Cancer: Duration of Treatment and Patients Who Benefit From It
FEATURING
Gerald Prager
- 214 views
- December 7, 2021
CECOG Academy
Entrectinib in Advanced NSCLC and Other Solid Tumors: Updates and New Findings
FEATURING
Artur Bandura
- 165 views
- December 7, 2021
- 2
CECOG Academy
Advances in IO Neoadjuvant Treatment With Immune Checkpoint Inhibitors for Solid Tumors
FEATURING
Christoph Zielinski
- 30 views
- December 7, 2021
CECOG Academy
Optimizing Immunotherapy for NSCLC in Daily Practice
FEATURING
Tanja Cufer
- 85 views
- December 7, 2021
- 1
CECOG Academy
Positioning Immune Checkpoint Inhibitor Treatment for TNBC
FEATURING
Rupert Bartsch
- 110 views
- December 7, 2021
CECOG Academy
Sequence of Treatment for Metastatic Prostate Cancer
FEATURING
Gero Kramer
- 358 views
- December 6, 2021